he FDA has allowed this =E200back door" as a pathway into the market place with no pre-=arket review or approval. If they are regulated solely under PHS sec. 361 =nd 21 C.F.R. Part 1271. To meet this criteria: 1) the cells have to be minimally manipulated 2) Homologous use not combined with another arti